Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2011, Article ID 959816, 9 pages
http://dx.doi.org/10.1155/2011/959816
Review Article

Mycoplasma genitalium: An Emerging Cause of Pelvic Inflammatory Disease

1Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 15261, USA
2Department of Epidemiology, Michigan State University, East Lansing, MI 48824, USA

Received 14 June 2011; Revised 10 September 2011; Accepted 13 September 2011

Academic Editor: Thomas Cherpes

Copyright © 2011 Catherine L. Haggerty and Brandie D. Taylor. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Williams, B. van der Pol, B. E. Batteiger et al., “Mycoplasma genitalium symptoms and concordance in sexual dyads,” International Society for STD Research Book of Abstracts, 2007. View at Google Scholar
  2. L. Falk, H. Fredlund, and J. S. Jensen, “Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection,” Sexually Transmitted Infections, vol. 81, no. 1, pp. 73–78, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. J. S. Huppert, J. E. Mortensen, J. L. Reed, J. A. Kahn, K. D. Rich, and M. M. Hobbs, “Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women,” Sexually Transmitted Diseases, vol. 35, no. 3, pp. 250–254, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. C. L. Haggerty, P. A. Totten, S. G. Astete et al., “Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease,” Sexually Transmitted Infections, vol. 84, no. 5, pp. 338–342, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. I. Simms, K. Eastick, H. Mallinson et al., “Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease,” Journal of Clinical Pathology, vol. 56, no. 8, pp. 616–618, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. C. R. Cohen, L. E. Manhart, E. A. Bukusi et al., “Association between Mycoplasma genitalium and acute endometritis,” Lancet, vol. 359, no. 9308, pp. 765–766, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. A. K. Tosh, B. van der Pol, J. D. Fortenberry et al., “Mycoplasma genitalium among Adolescent Women and their Partners,” Journal of Adolescent Health, vol. 40, no. 5, pp. 412–417, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. R. Thurman, O. Musatovova, S. Perdue, R. N. Shain, J. G. Baseman, and J. B. Baseman, “Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads,” International Journal of STD and AIDS, vol. 21, no. 3, pp. 177–183, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. V. Hjorth, E. Björnelius, P. Lidbrink et al., “Sequence-based typing of Mycoplasma genitalium reveals sexual transmission,” Journal of Clinical Microbiology, vol. 44, no. 6, pp. 2078–2083, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. C. Gaydos, N. E. Maldeis, A. Hardick, J. Hardick, and T. C. Quinn, “Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics,” Sexually Transmitted Diseases, vol. 36, no. 10, pp. 598–606, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. Centers for Disease Control and Prevention, Sexually Transmitted Disease Surveillance, 2004, U.S. Department of Health and Human Services, Atlanta, Ga, USA, 2005.
  12. C. L. McGowin and C. Anderson-Smits, “Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women,” PLoS Pathogens, vol. 7, no. 5, pp. 1–10, 2011. View at Publisher · View at Google Scholar · View at PubMed
  13. M. Uno, T. Deguchi, H. Komeda et al., “Mycoplasma genitalium in the cervices of Japanese women,” Sexually Transmitted Diseases, vol. 24, no. 5, pp. 284–286, 1997. View at Google Scholar · View at Scopus
  14. L. E. Manhart, C. W. Critchlow, K. K. Holmes et al., “Mucopurulent cervicitis and Mycoplasma genitalium,” Journal of Infectious Diseases, vol. 187, no. 4, pp. 650–657, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. J. Pépin, A. C. Labbé, N. Khonde et al., “Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers,” Sexually Transmitted Infections, vol. 81, no. 1, pp. 67–72, 2005. View at Publisher · View at Google Scholar · View at PubMed
  16. C. L. Haggerty and R. B. Ness, “Epidemiology, pathogenesis and treatment of pelvic inflammatory disease,” Expert Review of Anti-Infective Therapy, vol. 4, no. 2, pp. 235–247, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. E. H. Stephen and A. Chandra, “Declining estimates of infertility in the United States: 1982–2002,” Fertility and Sterility, vol. 86, no. 3, pp. 516–523, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. Centers for Disease Control and Prevention, Sexually Transmitted Disease Surveillance, 1997, Division of STD Prevention, U.S. Department of Health and Human Services, Atlanta, Ga, USA, 1998.
  19. A. E. Washington and P. Katz, “Cost of and payment source for pelvic inflammatory disease: trends and projections, 1983 through 2000,” Journal of the American Medical Association, vol. 266, no. 18, pp. 2565–2569, 1991. View at Publisher · View at Google Scholar · View at Scopus
  20. D. B. Rein, W. J. Kassler, K. L. Irwin, and L. Rabiee, “Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial,” Obstetrics and Gynecology, vol. 95, no. 3, pp. 397–402, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Westrom, “Decrease in incidence of women treated in hospital for acute salpingitis in Sweden,” Genitourinary Medicine, vol. 64, no. 1, pp. 59–63, 1988. View at Google Scholar · View at Scopus
  22. I. Simms, P. Rogers, and A. Charlett, “The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales,” International Journal of STD and AIDS, vol. 10, no. 7, pp. 448–451, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Westrom, R. Joesoef, G. Reynolds, A. Hagdu, and S. E. Thompson, “Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results,” Sexually Transmitted Diseases, vol. 19, no. 4, pp. 185–192, 1992. View at Google Scholar · View at Scopus
  24. R. B. Ness, D. E. Soper, R. L. Holley et al., “Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial,” American Journal of Obstetrics and Gynecology, vol. 186, no. 5, pp. 929–937, 2002. View at Google Scholar · View at Scopus
  25. S. L. Hillier, N. B. Kiviat, S. E. Hawes et al., “Role of bacterial vaginosis-associated microorganisms in endometritis,” American Journal of Obstetrics and Gynecology, vol. 175, no. 2, pp. 435–441, 1996. View at Google Scholar · View at Scopus
  26. N. B. Kiviat, P. Wolner-Hanssen, D. A. Eschenbach et al., “Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis,” American Journal of Surgical Pathology, vol. 14, no. 2, pp. 167–175, 1990. View at Google Scholar · View at Scopus
  27. D. E. Soper, N. J. Brockwell, H. P. Dalton, and D. Johnson, “Observations concerning the microbial etiology of acute salpingitis,” American Journal of Obstetrics and Gynecology, vol. 170, no. 4, pp. 1008–1017, 1994. View at Google Scholar · View at Scopus
  28. C. L. Haggerty, S. L. Hillier, D. C. Bass, and R. B. Ness, “Bacterial vaginosis and anaerobic bacteria are associated with endometritis,” Clinical Infectious Diseases, vol. 39, no. 7, pp. 990–995, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. J. F. Peipert, A. B. Montagno, A. S. Cooper, and C. J. Sung, “Bacterial vaginosis as a risk factor for upper genital tract infection,” American Journal of Obstetrics and Gynecology, vol. 177, no. 5, pp. 1184–1187, 1997. View at Google Scholar · View at Scopus
  30. R. P. Nugent, M. A. Krohn, and S. L. Hillier, “Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation,” Journal of Clinical Microbiology, vol. 29, no. 2, pp. 297–301, 1991. View at Google Scholar · View at Scopus
  31. H. C. Wiesenfeld, S. L. Hillier, M. A. Krohn et al., “Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease,” Obstetrics and Gynecology, vol. 100, no. 3, pp. 456–463, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. C. L. Haggerty, P. A. Totten, S. G. Astete, and R. B. Ness, “Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease,” Infectious Diseases in Obstetrics and Gynecology, vol. 2006, Article ID 30184, 5 pages, 2006. View at Publisher · View at Google Scholar · View at PubMed
  33. J. G. Tully, D. Taylor-Robinson, R. M. Cole, and D. L. Rose, “A newly discovered mycoplasma in the human urogenital tract,” Lancet, vol. 1, no. 8233, pp. 1288–1291, 1981. View at Google Scholar · View at Scopus
  34. P. A. Totten, M. A. Schwartz, K. E. Sjörström et al., “Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men,” Journal of Infectious Diseases, vol. 183, no. 2, pp. 269–276, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. J. S. Jensen, “Mycoplasma genitalium: a cause of non-gonococcal urethritis?” Genitourinary Medicine, vol. 70, no. 5, p. 363, 1994. View at Google Scholar · View at Scopus
  36. D. Taylor-Robinson, “Mycoplasma genitalium—an up-date,” International Journal of STD and AIDS, vol. 13, no. 3, pp. 145–151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. B. R. Moller, D. Taylor-Robinson, P. M. Furr, and E. A. Freundt, “Acute upper genital-tract disease in female monkeys provoked experimentally by Mycoplasma genitalium,” British Journal of Experimental Pathology, vol. 66, no. 4, pp. 417–426, 1985. View at Google Scholar · View at Scopus
  38. D. Taylor-Robinson, P. M. Furr, J. G. Tully, M. F. Barile, and B. R. Møller, “Animal models of Mycoplasma genitalium urogenital infection,” Israel Journal of Medical Sciences, vol. 23, no. 6, pp. 561–564, 1987. View at Google Scholar · View at Scopus
  39. C. L. McGowin, R. A. Spagnuolo, and R. B. Pyles, “Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation,” Infection and Immunity, vol. 78, no. 2, pp. 726–736, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. A. Baczynska, P. Funch, J. Fedder, H. J. Knudsen, S. Birkelund, and G. Christiansen, “Morphology of human Fallopian tubes after infection with Mycoplasma genitalium and Mycoplasma hominis—n vitro organ culture study,” Human Reproduction, vol. 22, no. 4, pp. 968–979, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. C. R. Cohen, N. R. Mugo, S. G. Astete et al., “Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis,” Sexually Transmitted Infections, vol. 81, no. 6, pp. 463–466, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. H. F. Svenstrup, J. Fedder, J. Abraham-Peskir, S. Birkelund, and G. Christiansen, “Mycoplasma genitalium attaches to human spermatozoa,” Human Reproduction, vol. 18, no. 10, pp. 2103–2109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Simms, J. M. Stephenson, H. Mallinson et al., “Risk factors associated with pelvic inflammatory disease,” Sexually Transmitted Infections, vol. 13, no. 18, 2002. View at Google Scholar
  44. M. Jurstrand, J. S. Jensen, A. Magnuson, F. Kamwendo, and H. Fredlund, “A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy,” Sexually Transmitted Infections, vol. 83, no. 4, pp. 319–323, 2007. View at Publisher · View at Google Scholar · View at PubMed
  45. C. Bjartling, S. Osser, and K. Persson, “The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy,” An International Journal of Obstetrics and Gynaecology, vol. 117, no. 3, pp. 361–364, 2010. View at Publisher · View at Google Scholar · View at PubMed
  46. P. Oakeshott, A. Aghaizu, P. Hay et al., “Is Mycoplasma genitalium in women the "new chlamydia?" A community-based prospective cohort study,” Clinical Infectious Diseases, vol. 51, no. 10, pp. 1160–1166, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. L. Westrom, “Effect of acute pelvic inflammatory disease on fertility,” American Journal of Obstetrics and Gynecology, vol. 121, no. 5, pp. 707–713, 1975. View at Google Scholar · View at Scopus
  48. R. Punnonen, P. Terho, V. Nikkanen, and O. Meurman, “Chlamydial serology in infertile women by immunofluorescence,” Fertility and Sterility, vol. 31, no. 6, pp. 656–659, 1979. View at Google Scholar · View at Scopus
  49. J. L. Kane, R. M. Woodland, and T. Forsey, “Evidence of chlamydial infection in infertile women with and without fallopian tube obstruction,” Fertility and Sterility, vol. 42, no. 6, pp. 843–848, 1984. View at Google Scholar · View at Scopus
  50. A. Miettinen, P. K. Heinonen, K. Teisala, K. Hakkarainen, and R. Punnonen, “Serologic evidence for the role of Chlamydia trachomatis, Neisseria Gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy,” Sexually Transmitted Diseases, vol. 17, no. 1, pp. 10–14, 1990. View at Google Scholar · View at Scopus
  51. S. Chutivongse, M. Kozuh-Novak, J. Annus et al., “Tubal infertility: serologic relationship to past chlamydial and gonococcal infection,” Sexually Transmitted Diseases, vol. 22, no. 2, pp. 71–77, 1995. View at Google Scholar
  52. G. Anestad, O. Lunde, M. Moen, and K. Dalaker, “Infertility and chlamydial infection,” Fertility and Sterility, vol. 48, no. 5, pp. 787–790, 1987. View at Google Scholar · View at Scopus
  53. H. F. Clausen, J. Fedder, M. Drasbek et al., “Serological investigation of Mycoplasma genitalium in infertile women,” Human Reproduction, vol. 16, no. 9, pp. 1866–1874, 2001. View at Google Scholar · View at Scopus
  54. H. F. Svenstrup, J. Fedder, S. E. Kristoffersen, B. Trolle, S. Birkelund, and G. Christiansen, “Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility—a prospective study,” Fertility and Sterility, vol. 90, no. 3, pp. 513–520, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. J. Grześko, M. Elias, B. Maczyńska, U. Kasprzykowska, M. Tłaczała, and M. Goluda, “Occurrence of Mycoplasma genitalium in fertile and infertile women,” Fertility and Sterility, vol. 91, no. 6, pp. 2376–2380, 2009. View at Publisher · View at Google Scholar · View at PubMed
  56. J. E. Korte, J. B. Baseman, M. P. Cagle et al., “Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium,” American Journal of Reproductive Immunology, vol. 55, no. 4, pp. 265–275, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. H. Moi, N. Reinton, and A. Moghaddam, “Mycoplasma genitalium in women with lower genital tract inflammation,” Sexually Transmitted Infections, vol. 85, no. 1, pp. 10–14, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. V. L. Short, P. A. Totten, R. B. Ness, S. G. Astete, S. F. Kelsey, and C. L. Haggerty, “Clinical presentation of Mycoplasma genitalium infection versus Neisseria Gonorrhoeae infection among women with pelvic inflammatory disease,” Clinical Infectious Diseases, vol. 48, no. 1, pp. 41–47, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. L. Falk, H. Fredlund, and J. S. Jensen, “Tetracycline treatment does not eradicate Mycoplasma genitalium,” Sexually Transmitted Infections, vol. 79, no. 4, pp. 318–319, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Paavonen, L. Westrom, and D. Escenbah, “Pelvic inflammatory disease,” in Sexually Transmitted Diseases, K. K. Holmes, P. F. Sparling, W. E. Stamm et al., Eds., pp. 1017–1050, McGraw–Hill, New York, NY, USA, 2008. View at Google Scholar
  61. J. D. C. Ross, L. Brown, P. Saunders, and S. Alexander, “Mycoplasma genitalium in asymptomatic patients: implications for screening,” Sexually Transmitted Infections, vol. 85, no. 6, pp. 436–437, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. S. D. Hillis, R. Joesoef, P. A. Marchbanks, J. N. Wasserheit, W. Cates, and L. Westrom, “Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility,” American Journal of Obstetrics and Gynecology, vol. 168, no. 5, pp. 1503–1509, 1993. View at Google Scholar · View at Scopus
  63. B. D. Taylor, R. B. Ness, T. Darville, and C. L. Haggerty, “Microbial correlates of delayed care for pelvic inflammatory disease,” Sexually Transmitted Diseases, vol. 38, no. 5, pp. 434–438, 2011. View at Publisher · View at Google Scholar · View at PubMed
  64. Centers for Disease Control and Prevention, “Sexually transmitted diseases treatment guidelines,” Morbidity and Mortality Weekly Report, vol. 59, pp. 1–110, 2010. View at Google Scholar
  65. G. E. Kenny, P. A. Young, M. C. Roberts, L. A. Manhart, and P. A. Totten, “An improved medium for growth of Mycoplasma genitalium: isolation of a tetracycline-resistant clinical strain,” ISSTDR Book of Abstracts, p. 389, 2007. View at Google Scholar
  66. H. Carlberg, E. Bjornelius, and J. S. Jensen, “Mycoplasma genitalium—the search for effective treatment,” International Journal of STD & AIDS, vol. 13, pp. 30–31, 2002. View at Google Scholar
  67. G. Johannisson, Y. Enström, G. B. Löwhagen et al., “Occurrence and treatment of Mycoplasma genitalium in patients visiting STD clinics in Sweden,” International Journal of STD and AIDS, vol. 11, no. 5, pp. 324–326, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. P. J. Horner, C. B. Gilroy, B. J. Thomas, R. O. M. Naidoo, and D. Taylor-Robinson, “Association of Mycoplasma genitalium with acute non-gonococcal urethritis,” Lancet, vol. 342, no. 8871, pp. 582–585, 1993. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Deguchi, T. Yoshida, S. Yokoi et al., “Longitudinal quantitative detection by real-time PCR of Mycoplasma genitalium in first-pass urine of men with recurrent nongonococcal urethritis,” Journal of Clinical Microbiology, vol. 40, no. 10, pp. 3854–3856, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. S. I. Maeda, M. Tamaki, K. Kojima et al., “Association of Mycoplasma genitalium persistence in the urethra with recurrence of nongonococcal urethritis,” Sexually Transmitted Diseases, vol. 28, no. 8, pp. 472–476, 2001. View at Google Scholar · View at Scopus
  71. P. C. T. Hannan, “Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro,” Journal of Medical Microbiology, vol. 47, no. 12, pp. 1115–1122, 1998. View at Google Scholar · View at Scopus
  72. C. S. Bradshaw, M. Y. Chen, and C. K. Fairley, “Persistence of Mycoplasma genitalium following azithromycin therapy,” PLoS ONE, vol. 3, no. 11, Article ID e3618, 2008. View at Publisher · View at Google Scholar · View at PubMed
  73. J. S. Jensen, C. S. Bradshaw, S. N. Tabrizi, C. K. Fairley, and R. Hamasuna, “Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance,” Clinical Infectious Diseases, vol. 47, no. 12, pp. 1546–1553, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. R. Hamasuna, Y. Osada, and J. S. Jensen, “Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5′ nuclease real-time PCR,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 12, pp. 4993–4998, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. P. Judlin, Q. Liao, Z. Liu, P. Reimnitz, B. Hampel, and P. Arvis, “Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study,” An International Journal of Obstetrics and Gynaecology, vol. 117, no. 12, pp. 1475–1484, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. P. Barry, K. Ahrens, A. Roger et al., “Prevalence and incidence of Mycoplasma genitalium and Trichomonas vaginalis infections among STD clinic patients determined by transcription mediated amplification San Francisco and Denver, 2004/2005,” International Society for STD Research Book of Abstracts, 2007. View at Google Scholar